tiprankstipranks
Trending News
More News >
Adaptimmune Therapeutics Plc. (ADAPY)
:ADAPY
US Market
Advertisement

Adaptimmune Therapeutics (ADAPY) Ownership - Who Owns Adaptimmune Therapeutics?

Compare
1,277 Followers

Adaptimmune Therapeutics (ADAPY) Ownership Overview

38.27%0.13%7.53%<0.01%54.07%
38.27% Insiders
7.53% Other Institutional Investors
<0.01% ETFs
54.07% Public Companies and
Individual Investors
The ownership structure of Adaptimmune Therapeutics (ADAPY) stock is a mix of institutional, retail, and individual investors. Approximately 7.66% of the company’s stock is owned by Institutional Investors, 38.27% is owned by Insiders, and 54.07% is owned by Public Companies and Individual Investors.
The ownership structure of Adaptimmune Therapeutics (ADAPY) stock is a mix of institutional, retail, and individual investors. Approximately 7.66% of the company’s stock is owned by Institutional Investors, 38.27% is owned by Insiders, and <0.01% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 29, 2025
xxxxxxxxxxxxx
$2070
Aug 19, 2025
xxxxxxxxxxxxx
$195000
Jul 30, 2025
xxxxxxxxxxxxx
$6744571

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
100,371,882Insider37.87%3,513,016
986,352Insider0.37%34,522
167,248Institution0.06%5,854
99,822Institution0.04%3,494
87,274Institution0.03%3,055
67,032Institution0.03%2,346
44,327Insider0.02%1,551
18,421Insider<0.01%645
16,257Institution<0.01%569
7,510Insider<0.01%263

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
167,248Institution0.06%5,854
99,822Institution0.04%3,494
67,032Institution0.03%2,346
16,257Institution<0.01%569
6,385Institution<0.01%223
554Institution<0.01%19

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,204Institution<0.01%35

FAQ

Who Owns Adaptimmune Therapeutics Plc. (ADAPY)?
According to the latest TipRanks data, approximately 7.53% of the company's stock is held by institutional investors, 38.27% is held by insiders, and 54.07% is held by retail investors.
    What percentage of Adaptimmune Therapeutics Plc. (ADAPY) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 7.53% of Adaptimmune Therapeutics Plc. (ADAPY) stock is held by institutional investors.
      What percentage of Adaptimmune Therapeutics Plc. (ADAPY) stock is held by retail investors?
      According to the latest TipRanks data, approximately 54.07% of Adaptimmune Therapeutics Plc. (ADAPY) stock is held by retail investors.
        Who owns the most shares of Adaptimmune Therapeutics Plc. (ADAPY)?
        Ecor1 Capital, Llc owns the most shares of Adaptimmune Therapeutics Plc. (ADAPY).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis